封面
市場調查報告書
商品編碼
1423029

2024-2032 年按動物類型(商業、伴侶)、產品類型(藥品、生物製品、藥用飼料添加劑、診斷)和地區分類的動物保健市場報告

Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球動物保健市場規模達378億美元。展望未來, IMARC Group預計到2032年市場規模將達到495億美元,2024-2032年複合年成長率(CAGR)為2.9%。寵物主人數量的增加及其對高品質獸醫護理的渴望、對人畜共患疾病的認知不斷提高以及眾多技術進步是推動市場的主要因素。

動物健康是指家養和野生動物的健康和正常功能狀態。它涵蓋動物的身體、心理和行為方面,強調它們的整體健康和生活品質。確保動物健康需要採取各種措施,例如預防保健、及時接種疫苗、適當的營養和定期獸醫護理。適當的動物健康管理對於動物個體的福祉以及預防和控制影響動物和人類的疾病的傳播至關重要。因此,動物健康在支持永續農業、野生動物保護和社會中人與動物的連結方面發揮著至關重要的作用。

對動物性蛋白質的需求不斷成長以及寵物擁有率的不斷成長將刺激預測期內市場的成長。此外,人們對人畜共患病的認知不斷提高,「同一個健康」方法強調了動物預防保健和疾病管理的重要性。與此一致的是,對新的和改進的動物健康解決方案的研發(R&D)的廣泛投資正在對市場成長產生積極影響。除此之外,獸醫領域的許多技術進步,例如提高動物健康干預措施有效性的創新診斷、藥物和治療方式,增加了對先進獸醫產品的需求。此外,旨在促進動物福利和生物安全的有利政府法規和措施正在推動市場成長。除此之外,對食品安全和品質的日益關注加速了動物保健產品在畜牧生產中的採用,以確保更健康、更安全的食品供應鏈。此外,由於新興經濟體可支配收入的增加,寵物照護方面的消費者支出不斷增加,也促進了市場的成長。

動物保健市場趨勢/促進因素:

日益關注預防保健

動物保健產業正在經歷向伴侶動物和牲畜預防性保健實踐的重大轉變。寵物主人和牲畜生產者認知到早期發現和積極管理健康問題的重要性,以改善動物的整體福祉並降低疾病風險。定期獸醫檢查、疫苗接種和量身定做的健康管理計劃正在變得司空見慣。這一趨勢的推動因素是提高動物生活品質並盡量減少畜牧生產中疾病爆發的經濟影響。因此,對預防性動物保健產品的需求不斷成長,包括疫苗、殺蟲劑和營養補充劑。

生物技術和製藥的進步

動物保健領域正在見證生物技術和製藥領域的顯著進步,改變了動物疾病的診斷和治療方式。尖端研究和創新技術促進了針對特定動物物種和條件的專門療法、疫苗和精準醫學的開發。基因編輯和細胞療法等生物技術突破為挑戰性疾病提供了有前景的解決方案。此外,製藥公司正在投資研發 (R&D),為動物創造更有效、更安全的藥物。這些進步改善了治療效果,並有助於提高動物保健的整體效率。獸醫專業人員現在可以提供更有針對性和個性化的治療計劃,從而為他們照顧的動物帶來更好的結果並提高生活品質。

不斷發展的寵物人性化和專業寵物護理

人類與寵物之間不斷發展的關係導致了一種被稱為寵物人性化的現象。寵物越來越被視為不可或缺的家庭成員,導致寵物照護市場的消費者行為發生重大轉變。寵物主人現在願意花更多錢購買優質、專業的寵物護理產品和服務,以確保他們心愛的伴侶過著健康、充實的生活。這一趨勢刺激了對高品質寵物營養產品、個人化治療和先進獸醫護理的需求。有機寵物食品、客製化補充劑和寵物專用醫療等各種特色產品的出現正在推動動物健康市場的成長。

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球動物保健市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔:依動物類型
  • 市場區隔:依產品類型
  • 市場區隔:按地區
  • 市場預測

第 6 章:市場區隔:依動物類型

  • 商業的
    • 市場走向
    • 市場預測
  • 伴侶
    • 市場走向
    • 市場預測

第 7 章:市場區隔:依產品類型

  • 藥品
    • 市場走向
    • 市場預測
  • 生物製品
    • 市場走向
    • 市場預測
  • 藥用飼料添加劑
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測

第 8 章:市場區隔:按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 9 章:全球動物保健產業:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章:全球動物保健產業:價值鏈分析

第 11 章:全球動物保健產業:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章:全球動物保健產業:價格分析

  • 主要價格指標
  • 價格結構
  • 利潤分析

第13章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bayer
    • Elanco
    • Merck
    • Merial
    • Zoetis Inc.
    • Biogenesis Bago
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Heska
    • Neogen
    • Novartis
    • Thermo Fisher Scientific
    • Vetoquinol
    • Virbac
Product Code: SR112024A1156

Abstract

The global animal health market size reached US$ 37.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The increasing number of pet owners and their desire for high-quality veterinary care, rising awareness of zoonotic diseases, and numerous technological advancements are some of the major factors propelling the market.

Animal health refers to the state of well-being and proper functioning of animals, both domestic and wild. It encompasses the physical, mental, and behavioral aspects of animals, emphasizing their overall health and quality of life. Ensuring animal health involves taking various measures, such as preventive healthcare, timely vaccinations, appropriate nutrition, and regular veterinary care. Proper management of animal health is essential for the welfare of individual animals and for preventing and controlling the spread of diseases that can impact both animal and human populations. As a result, animal health plays a crucial role in supporting sustainable agriculture, wildlife conservation, and the human-animal bond in society.

The rising demand for animal protein and the growing pet ownership rate will stimulate the growth of the market during the forecast period. Moreover, the heightening awareness of zoonotic diseases and the One Health approach have emphasized the importance of preventive care and disease management in animals. In line with this, extensive investments in research and development (R&D) of new and improved animal health solutions are positively influencing the market growth. Apart from this, numerous technological advancements in veterinary medicine, such as innovative diagnostics, pharmaceuticals, and treatment modalities that enhance the effectiveness of animal health interventions, has augmented the demand for advanced veterinary products. Additionally, favorable government regulations and initiatives aimed at promoting animal welfare and biosecurity are propelling the market growth. Besides this, the increasing focus on food safety and quality has accelerated the adoption of animal health products in livestock production to ensure healthier and safer food supply chains. Furthermore, the inflating consumer spending on pet care due to rising disposable incomes in emerging economies is contributing to the market growth.

Animal Health Market Trends/Drivers:

Increasing focus on preventive healthcare

The animal health industry is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet owners and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. Regular veterinary check-ups, vaccinations, and tailored health management plans are becoming commonplace. This trend is fueled by a desire to enhance the quality of life for animals and minimize the economic impact of disease outbreaks in livestock production. As a result, there is a growing demand for preventive animal health products, including vaccines, parasiticides, and nutritional supplements.

Advancements in biotechnology and pharmaceuticals

The animal health sector is witnessing remarkable advancements in biotechnology and pharmaceuticals, transforming the way diseases are diagnosed and treated in animals. Cutting-edge research and innovative technologies have led to the development of specialized therapies, vaccines, and precision medicine tailored to specific animal species and conditions. Biotechnological breakthroughs, such as gene editing and cell-based therapies, offer promising solutions for challenging diseases. Additionally, pharmaceutical companies are investing in research and development (R&D) to create more effective and safer medications for animals. These advancements improve treatment outcomes and contribute to the overall efficiency of animal healthcare. Veterinary professionals can now offer more targeted and personalized treatment plans, leading to better outcomes and enhanced quality of life for animals under their care.

Growing pet humanization and specialty pet care

The evolving relationship between humans and their pets has led to a phenomenon known as pet humanization. Pets are increasingly regarded as integral family members, resulting in a significant shift in consumer behavior in the pet care market. Pet owners are now willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend has catalyzed the demand for high-quality pet nutrition products, personalized treatments, and advanced veterinary care. The availability of a wide range of specialty products, such as organic pet food, customized supplements, and pet-specific medical treatments is propelling the growth of the market for animal health.

Animal Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global animal health market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on animal type and product type.

Breakup by Animal Type:

Commercial

Companion

Commercial holds the largest share in the market

A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes commercial and companion. According to the report, commercial accounted for the largest market share.

The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, has augmented the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus favoring the market growth.

Breakup by Product Type:

Pharmaceuticals

Biologicals

Medicinal Feed Additives

Diagnostics

Pharmaceuticals represent the most popular product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes pharmaceuticals, biologicals, medicinal feed additives, and diagnostics. According to the report, pharmaceuticals represented the largest segment.

Pharmaceuticals refer to essential medications and therapies used to address a wide range of health conditions in animals. These pharmaceutical products cater to both companion animals and livestock, helping prevent and treat diseases, manage chronic conditions, and enhance overall animal well-being. Veterinary pharmaceutical companies are investing heavily in research and development (R&D) to create innovative and effective drugs tailored to specific animal species and health needs, thereby contributing to the segment growth. Moreover, continuous advancements in pharmaceutical technologies, such as controlled-release formulations and personalized medicine, further optimizes treatment outcomes. Additionally, pharmaceutical companies are collaborating with veterinarians, animal owners, and regulatory authorities to ensure product safety, efficacy, and compliance with stringent quality standards. Furthermore, the increasing demand for animal healthcare and the growing importance of preventive medicines are propelling the market growth.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region has a large population of pet owners who prioritize the health and well-being of their companion animals, which has augmented demand for veterinary products and services. Moreover, the expanding livestock industry in North America fuels the need for animal health solutions to ensure the health and productivity of the commercial animal sector. Additionally, the presence of leading pharmaceutical companies and research institutions in the region that fosters continuous innovation in animal health products, including vaccines, pharmaceuticals, and diagnostics has catalyzed the market growth. Another major contributing aspect is the introduction of supportive government regulations and initiatives promoting animal welfare and biosecurity, encouraging investments in the animal health industry, thereby propelling the market growth.

Competitive Landscape:

The market is experiencing steady growth as key players are introducing several cutting-edge innovations to address evolving challenges and enhance animal care. They are developing advanced vaccines and therapeutics targeting specific diseases prevalent in both companion animals and livestock. Additionally, novel diagnostic tools employing advanced technologies, such as DNA testing and point-of-care devices, have been introduced by manufacturers to enable faster and more accurate disease detection. Key players are also investing in telemedicine and digital health solutions, facilitating remote consultations and personalized treatment plans for pet owners. Furthermore, the integration of data analytics and artificial intelligence (AI) technologies has improved decision-making in animal health management, optimizing treatment protocols and predictive modeling. These latest innovations by leading players in the market reflect their commitment to delivering state-of-the-art solutions and driving the animal health industry toward a more efficient and compassionate approach to animal care. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain during the forecast period (2024-2032).

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Bayer

Elanco

Merck

Merial

Zoetis Inc.

Biogenesis Bago

Boehringer Ingelheim

Ceva Sante Animale

Heska

Neogen

Novartis

Thermo Fisher Scientific

Vetoquinol

Virbac

Recent Developments:

In January 2022, Zoetis Inc., a leading animal health company, announced the U.S. Food and Drug Administration (FDA) approval of a new label indication for their product, SimparicaTrio. This groundbreaking approval grants SimparicaTrio, a chewable tablet containing sarolaner, moxidectin, and pyrantel, an extended purpose for the prevention of Borrelia burgdorferi infections in dogs. The approval is a testament to the product's potent tick-killing properties, which not only protect dogs but also contribute to the prevention of tick-borne diseases.

In January 2021, Boehringer Ingelheim, a prominent player in the animal health industry, unveiled a strategic collaboration with PetMedix, a renowned biotechnology company specializing in companion animal therapeutics. This partnership aims to harness the innovative potential of PetMedix's proprietary Ky9 platform, which is designed to develop cutting-edge antibody therapeutics for companion animals. Boehringer Ingelheim's involvement in this joint venture will focus on leveraging its extensive expertise in market access, regulatory approvals, and commercialization to bring these groundbreaking therapies to the global market.

In September 2020, Ceva Sante Animale, a leading animal health company, made a groundbreaking announcement regarding a substantial expansion in its production capacity for bacterial autogenous vaccines at its manufacturing facility in France. This impressive development represents a three-fold increase in production capability, achieved through an ambitious and forward-thinking project backed by an investment of USD 8 million. The primary focus of this innovative venture is to bolster preventative animal health measures, particularly by enhancing the availability and accessibility of bacterial autogenous vaccines.

Key Questions Answered in This Report

  • 1. What was the size of the global animal health market in 2023?
  • 2. What is the expected growth rate of the global animal health market during 2024-2032?
  • 3. What are the key factors driving the global animal health market?
  • 4. What has been the impact of COVID-19 on the global animal health market?
  • 5. What is the breakup of the global animal health market based on the animal type?
  • 6. What is the breakup of the global animal health market based on the product type?
  • 7. What are the key regions in the global animal health market?
  • 8. Who are the key players/companies in the global animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Animal Type
  • 5.5 Market Breakup by Product Type
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Commercial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Companion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Pharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biologicals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medicinal Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Animal Health Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Animal Health Industry: Value Chain Analysis

11 Global Animal Health Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Animal Health Industry: Price Analysis

  • 12.1 Key Price Indicators
  • 12.2 Price Structure
  • 12.3 Margin Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Bayer
    • 13.3.2 Elanco
    • 13.3.3 Merck
    • 13.3.4 Merial
    • 13.3.5 Zoetis Inc.
    • 13.3.6 Biogenesis Bago
    • 13.3.7 Boehringer Ingelheim
    • 13.3.8 Ceva Sante Animale
    • 13.3.9 Heska
    • 13.3.10 Neogen
    • 13.3.11 Novartis
    • 13.3.12 Thermo Fisher Scientific
    • 13.3.13 Vetoquinol
    • 13.3.14 Virbac

List of Figures

  • Figure 1: Global: Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Animal Health Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Animal Health Market: Breakup by Animal Type (in %), 2023
  • Figure 4: Global: Animal Health Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Animal Health Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Animal Health Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Animal Health Industry: SWOT Analysis
  • Figure 8: Global: Animal Health Industry: Value Chain Analysis
  • Figure 9: Global: Animal Health Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Animal Health (Commercial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Animal Health (Commercial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Animal Health (Companion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Animal Health (Companion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Animal Health (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Animal Health (Biologicals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Animal Health (Biologicals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Animal Health (Medicinal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Animal Health (Medicinal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Animal Health (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Animal Health (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Europe: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Europe: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Asia Pacific: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Asia Pacific: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Latin America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Latin America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Animal Health Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Animal Health Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
  • Table 3: Global: Animal Health Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 4: Global: Animal Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Animal Health Market: Competitive Structure
  • Table 6: Global: Animal Health Market: Key Players